← All Biolase, INC filings

Biolase, INC DEF 14A proxy statements

Proxy statements, covering the matters put to shareholders at the annual meeting — board elections, auditor ratification and executive pay.

OTC.Pink
BIOLQ
Biolase, INC
DEFA14A: BIOLASE, Inc. Seeks Stockholder Approval for Key Proposals at 2024 Annual Meeting
BIOLASE, Inc. is holding its annual stockholder meeting on May 2, 2024, seeking approval for director elections, executive compensation, warrant exercises, an incentive plan amendment, auditor ratification, and a potential reverse stock split.
OTC.Pink
BIOLQ
Biolase, INC
DEF 14A: BIOLASE Seeks Stockholder Approval for Key Proposals Including Reverse Stock Split and Warrant Exercises
BIOLASE, Inc. is convening its 2024 annual meeting of stockholders to vote on director elections, executive compensation, warrant exercises, a long-term incentive plan amendment, auditor ratification, and a potential reverse stock split.